Evaluation of anti-nuclear antibodies and kidney pathology in Lewis rats following exposure to Libby amphibole asbestos

Journal of Immunotoxicology

Volumn 10, Issue 4, 2013, Pages 329-333

  Salazar, Keith D ^a   Copeland, Carey B ^b   Wood, Charles E ^c   Schmid, Judith E ^d   Luebke, Robert W ^b,d  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b Environmental Public Health Division Genomics Core   (United States)

^c Integrated Systems Toxicology Division   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Anti nuclear antibodies; Asbestos; Kidney; Systemic lupus erythematosus

Indexed keywords

AMOSITE; AMPHIBOLE; ANTINUCLEAR ANTIBODY; DOUBLE STRANDED DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EXPOSURE; FEMALE; KIDNEY DISEASE; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ASBESTOS, AMOSITE; ASBESTOS, AMPHIBOLE; BIOLOGICAL MARKERS; ENVIRONMENTAL EXPOSURE; FEMALE; HISTIDINE-TRNA LIGASE; HUMANS; INCIDENCE; INTUBATION, INTRATRACHEAL; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MONTANA; PREVALENCE; PROTEINURIA; RATS; RATS, INBRED LEW;

EID: 84888031064     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.3109/1547691X.2012.747230     Document Type: Article

References (25)

1. ACR (American College of Rheumatology). 1997. Revised Criteria for Classification of Systemic Lupus Erythematosus. Available at: http://www.rheumatology.org/practice/clini-cal/classification/SLE/ 1997-update-of-the-1982-acr-revised-criteria-for-classification-of-sle.pdf [last accessed 18 June 2012].
2. Blake, D. J., Wetzel, S. A., and Pfau, J. C. 2008. Autoantibodies from mice exposed to Libby amphibole asbestos bind SSA/Ro52-enriched apoptotic blebs of murine macrophages. Toxicology 246:172-179.
3. Bolton, W. K., Benton, F. R., Maclay, J. G., and Sturgill, B. C. 1976. Spontaneous glomerular sclerosis in aging Sprague-Dawley rats. I. Lesions associated with mesangial IgM deposits. Am. J. Pathol. 85:277-302.
4. Davis 3rd, J. M., Moder, K. G., Homburger, H. A., and Ytterberg, S. R. 2005. Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: Evidence for autoimmunity including neurologic and connective tissue diseases. Medicine (Baltimore) 84:208-217.
5. Fenton, K., Fismen, S., Hedberg, A., et al. 2009. Anti-dsDNA antibodies promote initiation, and acquired loss of renal DNAse1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice. PLoS ONE 4:e8474.
6. Hassan A. B, Lundberg I. E., Isenberg D. and Wahren-Herlenius M., 2002. Serial analysis of Ro/SSA and La/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus. Scand. J Rheumatol 31:133-9.
7. Katsumata, Y., Ridgway, W. M., Oriss, T., et al. 2007. Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation. J. Autoimmun. 29:174-186.
8. Kumar, Y., Bhatia, A., and Minz, R. W. 2009. Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: A journey revisited. Diagn. Pathol. 4:1.
9. Kurien, B. T., and Scofield, R. H. 2006. Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand. J. Immunol. 64: 227-235.
10. Levine, S. M., Raben, N., Xie, D., et al. 2007. Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis. Arthritis Rheum. 56:2729-2739.
11. Li, Q. Z., Karp, D. R., Quan, J., et al. 2011. Risk factors for ANA positivity in healthy persons. Arthritis Res. Ther. 13:R38.
12. Meeker, G. P., Bern, A. M., Brownfield, I. K., et al. 2003. The composition and morphology of amphiboles from the Rainy Creek Complex, near Libby, Montana. Am. Mineralogist 88:1955-1969.
13. Mossman, B. T., Bignon, J., Corn, M., et al. 1990. Asbestos: scientific developments and implications for public policy. Science 247:294-301.
14. Noonan, C. W., Pfau, J. C., Larson, T. C., and Spence, M. R. 2006. Nested case-control study of autoimmune disease in an asbestos-exposed population. Environ. Health Perspect. 114:1243-1247.
15. Padilla-Carlin, D. J., Schladweiler, M. C., Shannahan, J. H., et al. 2011. Pulmonary inflammatory and fibrotic responses in F344 rats after intratracheal instillation exposure to Libby amphibole. J. Toxicol. Environ. Health 74:1111-1132.
16. Pfau, J. C., Sentissi, J. J., Li, S., et al. 2008. Asbestos-induced autoimmunity in C57BL/6 mice. J. Immunotoxicol. 5:129-137.
17. Pfau, J. C., Sentissi, J. J., Weller, G., and Putnam, E. A. 2005. Assessment of autoimmune responses associated with asbestos exposure in Libby, Montana, USA. Environ. Health Perspect. 113:25-30.
18. Salazar, K. D., Copeland, C. B., and Luebke, R.W. 2012. Effects of Libby amphibole asbestos exposure on two models of arthritis in the Lewis rat. J. Toxicol. Environ. Health 75:351-365.
19. Sauty, A., Rochat, T., Schoch, O. D., et al. 1997. Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur. Respir. J. 10:2907-2912.
20. Shannahan, J. H., Ghio, A. J., Schladweiler, M. C., et al. 2011. The role of iron in Libby amphibole-induced acute lung injury and inflammation. Inhal. Toxicol. 23:313-323.
21. Shannahan, J. H., Schladweiler, M. C., Thomas, R. F., et al. 2012. Vascular and thrombogenic effects of pulmonary exposure to Libby amphibole. J. Toxicol. Environ. Health 75:213-231.
22. Tan, E. M., Feltkamp, T. E., Smolen, J. S., et al. 1997. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum. 40:1601-1611.
23. Turner-Warwick, M., and Parkes, W. R. 1970. Circulating rheumatoid and antinuclear factors in asbestos workers. Br. Med. J. 3:492-495.
24. Webber, J. S., Blake, D. J., Ward, T. J., and Pfau, J. C. 2008. Separation and characterization of respirable amphibole fibers from Libby, Montana. Inhal. Toxicol. 20:733-740.
25. Wofsy, D., and Seaman, W. E. 1985. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161:378-391.